Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 22Gastrointestinal 16Head & Neck 15Genitourinary 15Gynecologic 12CNS 8Tumor-Agnostic 7Lymphoid 6Thoracic 5Other hematologic neoplasm 5Sarcoma 4Endocrine 3Plasma cell 2Other solid neoplasm 2Dermatologic 2Other neoplasm 1Other 1Classical hematology 1

Conditions

Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System 1

Interventions

fludarabine 2Taxes 2Specimen Handling 2Paclitaxel 2Melphalan 2Magnetic Resonance Spectroscopy 2Educational Status 2Aminolevulinic Acid 2venetoclax 1tirbanibulin 1taxane 1radium Ra 223 dichloride 1fludarabine phosphate 1abemaciclib 1X-Rays 1Whole-Body Irradiation 1Tamoxifen 1Tacrolimus 1Surveys and Questionnaires 1Robotic Surgical Procedures 1Resistance Training 1Radiotherapy 1Platinum 1Photons 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Mycophenolic Acid 1Morphine 1Methods 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Surveys and Questionnaires × Other neoplasm × 90 days × Clear all
NCT03028337 2026-03-05

Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
80 enrolled
CNSOther neoplasm

Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon âš¡